LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding LENZ Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 60 | 58 | −2 |
| Shares | 36.0M | 34.7M | −1.24M (−3.4%) |
| Value | $587.4M | $431.7M | −$155.7M (−26.5%) |
New holders (9)
Institutions that held LENZ Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EcoR1 Capital, LLC | 688,900 | $8.56M | 0.27% |
| OUP Management Co., LLC | 406,308 | $5.05M | 2.28% |
| Ergoteles LLC | 72,155 | $897.0K | 0.03% |
| Jane Street Group, LLC | 41,860 | $520.0K | 0.00% |
| Jefferies Group LLC | 30,074 | $373.8K | 0.01% |
| Virtus ETF Advisers LLC | 15,855 | $197.0K | 0.07% |
| ProShare Advisors LLC | 11,730 | $147.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 6,714 | $83.0K | 0.00% |
| Daiwa Securities Group Inc. | 169 | $2.00K | 0.00% |
Sold out (11)
Institutions that held LENZ Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Janus Henderson Group PLC | 958,079 | $15.2M |
| Deerfield Management Company, L.P. (Series C) | 906,308 | $14.9M |
| Jennison Associates LLC | 296,375 | $4.86M |
| HighVista Strategies LLC | 60,905 | $998.0K |
| D. E. Shaw & Co., Inc. | 53,472 | $876.0K |
| Caas Capital Management LP | 40,000 | $656.0K |
| Ghisallo Capital Management LLC | 15,000 | $246.0K |
| SG Americas Securities, LLC | 7,247 | $119.0K |
| MetLife Investment Management | 6,861 | $112.5K |
| Metropolitan Life Insurance Co | 5,191 | $85.1K |
| Point72 Asset Management, L.P. | 5,000 | $82.0K |